Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
Anxiolytics (Milestones in Drug Therapy) M. - 12 Angebote vergleichen
Preise | 2012 | 2013 | 2014 | 2016 | 2023 |
---|---|---|---|---|---|
Schnitt | € 133,72 | € 135,79 | € 208,80 | € 199,18 | € 106,99 |
Nachfrage |
Anxiolytics (2015)
ISBN: 9783034895811 bzw. 303489581X, in Deutsch, SPRINGER VERLAG GMBH 01/06/2015, Taschenbuch, neu.
New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. This item is printed on demand.
Anxiolytics (2012)
ISBN: 9783034895811 bzw. 303489581X, in Deutsch, Birkhäuser, Taschenbuch, neu.
9783034895811 Paperback, This listing is a new book, a title currently in-print which we order directly and immediately from the publisher.
Anxiolytics (2012)
ISBN: 9783034895811 bzw. 303489581X, in Deutsch, Birkhäuser Okt 2012, Taschenbuch, neu, Nachdruck.
This item is printed on demand - Print on Demand Titel. Neuware - For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal. 181 pp. Englisch.
Anxiolytics
ISBN: 9783764360320 bzw. 3764360321, in Deutsch, Springer Basel AG, neu.
Von Händler/Antiquariat, Versandbuchhandlung Kisch & Co. [3338288].
Neuware - For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal. Buch, Neuware, 23.5x15.5x cm, 1000g.
Anxiolytics (2000)
ISBN: 9783764360320 bzw. 3764360321, in Deutsch, Springer Basel AG Sep 2000, neu.
Von Händler/Antiquariat, Agrios-Buch [57449362], Bergisch Gladbach, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Anxiolytics (2000)
ISBN: 9783764360320 bzw. 3764360321, in Deutsch, Springer Basel AG Sep 2000, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Anxiolytics (2012)
ISBN: 9783034895811 bzw. 303489581X, in Deutsch, Birkhäuser Okt 2012, Taschenbuch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Anxiolytics
ISBN: 9783764360320 bzw. 3764360321, vermutlich in Englisch, Springer Nature, gebundenes Buch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Anxiolytics
ISBN: 9783034895811 bzw. 303489581X, vermutlich in Englisch, Springer Nature, Taschenbuch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Anxiolytics
ISBN: 9783034895811 bzw. 303489581X, in Deutsch, Birkhäuser, Taschenbuch, neu.
Von Händler/Antiquariat, Rhein-Team Lörrach, [3332481].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen